Sabby Management, LLC Ocular Therapeutix, Inc Transaction History

Sabby Management, LLC

  • $9.65 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $874,720 - $1.71 Million
-142,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.7 - $14.34 $1.19 Million - $1.76 Million
122,783 Added 638.93%
142,000 $1.42 Million
Q2 2021

Aug 16, 2021
BUY
$13.43 - $19.16 $133,856 - $190,967
9,967 Added 107.75%
19,217 $273,000
Q1 2021

May 17, 2021
BUY
$15.82 - $22.11 $146,335 - $204,517
9,250 New
9,250 $152,000

Others Institutions Holding OCUL

# of Institutions
189
Shares Held
132M
Call Options Held
374K
Put Options Held
179K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $560M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email